February 11, 2026

Indica Labs Sets New Standard for Molecular Testing in Breast Cancer with Expansion of AI Macrodissection Portfolio

Albuquerque, NM, February 10, 2025 – Indica Labs, the world’s leading provider of AI-powered digital pathology solutions, today announced the expansion of its macrodissection portfolio with the launch of Breast Macrodissect AI. The suite now includes advanced...

recent articles

Philips: Fully interoperable smart imaging systems and informatics solutions connect teams in radiology, oncology, cardiology and pathology to enhance clinical confidence and advance precision in diagnosis and treatment Vienna, Austria and...

Dive Deeper into Data-Driven Pathology at USCAP 2023 with DeepBio. USCAP 2023, find us at booth #349 to learn more about our flagship product DeepDx® Prostate, among others, and what values they bring to pathology. Moreover, don't miss...

Indica Labs announces part one of Multiplex IHC webinar. Masterclass Webinar 1: Optimizing a 3-plex Multiplex IHC Assay Using Roche Discovery Reagents and HALO® Image Analysis Date: May 11, 2023 Time: 8 am PST | 11 am EST |...

Proscia: Providing faster, higher quality results with enterprise digital pathology NASHVILLE and PHILADELPHIA – March 1, 2023 – Proscia®, a leading provider of digital and computational pathology solutions, today announced that...

WHITE PLAINS, N.Y., Feb. 27, 2023 /PRNewswire/ -- Clarapath, a robotics company aimed at catalyzing change in the way pathology laboratories process human and animal tissue, today announced the acquisition of Mountain View,...

Us2.ai: FDA-cleared AI decision support to process full echo reports with zero clicks in under 2 minutes1 SINGAPORE--(BUSINESS WIRE)--Us2.ai, a Singapore-based medtech firm backed by IHH Healthcare, Heal Partners and...

OR

platinum partners

gold partners

Silver Partners

Media Partners